Christian Lund joins Abzu’s board of directors.

Christian Lund, co-founder of Templafy, joins the board of directors at Abzu®, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies.

Christian Lund joins Abzu board of directors

Christian Lund, co-founder of Templafy.

Christian Lund, Co-founder of Templafy, joins the board of directors at Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies. This appointment will notably expedite Abzu’s path to commercializing its groundbreaking AI in business operations, transcending human capacity constraints to transform the future of work.

“We are thrilled to have Christian join our board of directors,” says Casper Wilstrup, CEO and founder of Abzu. “We share a foundational belief on how technology – specifically AI – should transform work. And with Christian’s expertise in SaaS and product commercialization, we are poised to bring the adaptable, problem-solving capabilities of our exceptional AI beyond pharma R&D to mission-critical problems in the enterprise.”

Abzu’s AI, built in-house on their patented technology, has the unique characteristic of explainability not seen in traditional “black-box” machine learning models. “What attracted me to Abzu was their high-performing and explainable technology,” says Christian. “And what made me excited to accelerate their journey is their AI’s unique potential to transform knowledge work. Not just by automating tasks, which lacks real long-term impact on complex problems, but by its potential to own the operational tasks that it is delegated. And only a rational AI that makes explainable, evidence-based decisions can own and transform fragmented workflows while minimizing regulatory compliance risks.”

Founded in 2018, Abzu established itself as a global leader in explainable, rational, and safe AI in the pharmaceutical industry, contributing to new discoveries in disease understanding and RNA therapeutics. Today, Abzu’s technology accelerates new insights and understanding in pharma R&D and transforms critical and complex business processes for enterprise operations.

About Christian Lund.

Christian Lund is the co-founder of Templafy, an enterprise-grade productivity and governance platform for enterprise document, presentation, and email creation. With over 15 years of domain knowledge, Christian helped spearhead the transition for large organizations from on-premise systems to software-as-a-service solutions for document content and template management. Templafy is now a global leader in its category, serving many of the largest international organizations and over 3.8 million users. 1.5 million users.

Outside of Templafy, Christian is an active tech investor and advisor and enjoys helping startups shape scalable businesses.

About Abzu.

Founded in 2018, Abzu® builds trustworthy AI to tackle complex challenges for the world’s leading companies. Abzu established itself as a global leader in explainable, rational, and safe AI in the pharmaceutical industry, contributing to new discoveries in disease understanding and RNA therapeutics. Today, Abzu’s technology accelerates new insights and understanding in pharma R&D and transforms critical and complex business processes for enterprise operations.

Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to CoolVendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards. For more information, visit www.abzu.ai.

Share this press release.

The latest press releases from Abzu.

Abzu leads the way in disease understanding and drug design.

Abzu welcomes Kasper Sommer as its new CFO.

October 4, 2023
Abzu, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world's leading companies., welcomes Kasper Sommer as its new Chief Financial Officer.

Abzu earns ISO 27001:2022 certification: Elevating trust with ISO-certified AI.

October 3, 2023
Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies, secures ISO 27001:2022 certification, reinforcing its value proposition for explainable, resilient, and safe AI solutions.

Abzu’s explainable AI used in NASA GeneLab study to explain skin disorders in space.

September 12, 2023
Scientists at Abzu and NASA GeneLab have identified gene combinations that explain the origin of rashes astronauts develop during space missions

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.